ArticleScience advances2021
Interdependent program evaluation: Geographic and social spillovers in COVID-19 closures and reopenings in the United States.
Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Serum per- and polyfluoroalkyl substances (PFAS) concentrations and anti-spike SARS-CoV-2 IgG levels following COVID-19 vaccination: A cross-sectional study in three communities with elevated PFAS exposure.International journal of hygiene and environmental health · 2026Article
- Social, mobility and contact networks in shaping health behaviours and infectious disease dynamics: a scoping review.Infectious diseases of poverty · 2025Article
- The impact of confounders, spillovers and interactions on social distancing policy effects estimates.Scientific reports · 2025Article
- Indirect and direct effects of nighttime light on COVID-19 mortality using satellite image mapping approach.Scientific reports · 2024Article
- Quantifying the spatial spillover effects of non-pharmaceutical interventions on pandemic risk.International journal of health geographics · 2023Article
- Comparing modelling approaches for the estimation of government intervention effects in COVID-19: Impact of voluntary behavior changes.PloS one · 2023Article
- One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk.Science advances · 2022Article
- Infectiousness of places - Impact of multiscale human activity places in the transmission of COVID-19.npj urban sustainability · 2022Article
- Tracking and Controlling the Spatiotemporal Spread of SARS-CoV-2 Lineage B.1.1.7 in COVID-19 Reopenings.GeoHealth · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In an interconnected world, understanding policy spillovers is essential. We propose a program evaluation framework to measure policy spillover effects and apply that framework to study the governmental responses to COVID-19 in the United States. Our analysis suggests the presence of social spillovers. We estimate that while state closures directly reduced mobility by 3 to 4%, all other states locking down further decreased mobility in the focal state by 8 to 14%. Similarly, while reopening directly increased mobility by 2 to 3%, all other states' reopening increased mobility in the focal state by 12 to 21%. Our analysis also suggests geographic spillovers: Travel from locked down origins to open destinations increased by 12 to 29%. In contrast, travel from reopened origins to locked down destinations decreased by 6 to 7% for nearby counties and by 14 to 18% for distant counties. Despite its limitations, we believe that our approach takes the first steps toward creating a framework for interdependent program evaluation across policy domains.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.